Massachusetts General Hospital

Early signs of Alzheimer's disease, like memory loss, confusion, and mood changes, can be subtle but significant. Learn more about this disease and as a system, Mass General Brigham will continue to work toward breakthroughs in treatment and care. https://spklr.io/6049xVuh #EndAlz #AlzheimersAwareness

A Path Paved with Gemstones | Submitted by Fleur Lobo, PhD from the Zhang Lab In this photo, we can see a section of a brain with Alzheimer's. When someone suffers from Alzheimer's, their brain cells start to die and their memory and other important mental functions deteriorate over time. This is a process called neurodegeneration. Right now, over 6.7 million Americans are suffering from this disease, and in this photo, we can see a protein called Tau (magenta) that actually helps protect against the process of neurodegeneration. Researchers like Dr. Lobo from the Mass General Research Institute Zhang Lab are currently investigating how small molecules in our brains interact with this protective protein Tau, and how it can help us prevent Alzheimer's in the future. #AlzheimersMonth

We proudly recognize and celebrate the brave people who have served in the armed forces—both past and present. We are especially grateful for the veterans and military family members within our system who bring their dedication, leadership, and commitment to excellence into everything they do. We honor your service, sacrifice, and the many ways you continue to make a difference in our communities and workplaces. #VeteransMonth

We’re pleased to announce that more than 80 researchers across the Mass General Brigham system have been named to the annual Highly Cited Researchers 2024 list from Clarivate. See the full list: https://spklr.io/6042xkmj

Preventing heart attacks starts with a heart-healthy lifestyle and regular checkups. Know your risk factors—family history, cholesterol, blood pressure and more. https://spklr.io/6041x6PJ

David Roach, MD, infectious diseases specialist, has developed a low-cost way to track antibiotic-resistant infections. The impact could be global. https://spklr.io/6046xB84

The newly established John and Ashley Ranelli Endowed Scholar in Cancer Innovation, with Matthew Frigault, MD, as the inaugural incumbent, will support visionary physician-scientists in their pursuit of new ideas at Mass General Cancer Center. “We are incredibly grateful for this important funding from the Ranelli Family,” says Ephraim Hochberg, MD. “Their crucial support will bolster Mass General’s position as a leader in cancer care innovation and expand opportunities for physician-scientists who will deliver hope and life to the patients of tomorrow.” https://spklr.io/6047xHCf #MassGeneralGiving

We are excited to announce the Quantum Award recipients: Lloyd Bod, PhD, William L. Hwang, MD, PhD, David T. Ting, MD, and Alexandra-Chloe Villani, PhD. The team may receive up to $1 million per year for two years to explore potentially life-threatening complications that can accompany even the most successful cancer immunotherapies, seeking to separate the benefit from side effects, and enhance the successful treatment of multiple cancers. Congratulations! Learn more: https://spklr.io/6041xH2F

Heartburn or heart attack? The symptoms can be similar, but knowing the difference could save your life. Learn what to watch for and when to act fast. https://spklr.io/6040x6PA

On November 16-18, 2024, heart and vascular experts from Mass General Brigham will join thousands of colleagues in raising awareness and improving cardiovascular (CV) health at this year’s American Heart Association (AHA) Scientific Sessions in-person in Chicago. Mass General Brigham is proud to present their latest cardiovascular research and evidence-driven clinical recommendations alongside other cardiovascular experts from across the globe. Topics include aortic disease, maternal CV disease, coronary artery disease, cardiomyopathies and more. https://spklr.io/6046xH3C #AHA24